SPX3,911.74+116.01 3.06%
DIA315.02+8.28 2.70%
IXIC11,607.62+375.43 3.34%

BeiGene Secures China's Approval for Tislelizumab Treatment for Nasopharyngeal Cancer; Shares Climb Premarket

MT Newswires · 06/10/2022 03:19

Please log in to view news